Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 70.08 Billion KRW | 236.21% |
| 2022 | -16.88 Billion KRW | -161.69% |
| 2021 | 30.53 Billion KRW | 69.93% |
| 2020 | 6.91 Billion KRW | -25.69% |
| 2019 | 98.09 Billion KRW | -18.7% |
| 2018 | 61.2 Billion KRW | 975.31% |
| 2017 | -19.87 Billion KRW | -94.38% |
| 2016 | 60.33 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 9.67 Billion KRW | 1844.31% |
| 2024 Q1 | -3.22 Billion KRW | 121.93% |
| 2023 FY | - KRW | 236.21% |
| 2023 Q2 | 11.64 Billion KRW | -31.24% |
| 2023 Q3 | 4.59 Billion KRW | -60.58% |
| 2023 Q4 | -8.59 Billion KRW | -287.07% |
| 2023 Q1 | 16.94 Billion KRW | 195.35% |
| 2022 Q2 | 2.22 Billion KRW | 18.27% |
| 2022 FY | - KRW | -161.69% |
| 2022 Q4 | -17.76 Billion KRW | -145.94% |
| 2022 Q3 | -7.22 Billion KRW | -424.8% |
| 2022 Q1 | 1.88 Billion KRW | -79.19% |
| 2021 Q4 | 9.03 Billion KRW | 24.91% |
| 2021 FY | - KRW | 69.93% |
| 2021 Q3 | 7.23 Billion KRW | 0.0% |
| 2020 FY | - KRW | -25.69% |
| 2019 FY | - KRW | -18.7% |
| 2018 FY | - KRW | 975.31% |
| 2017 FY | - KRW | -94.38% |
| 2016 FY | - KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HLB Co., Ltd. | -172.27 Billion KRW | 140.683% |
| iNtRON Biotechnology, Inc. | -6.23 Billion KRW | 1224.169% |
| BINEX Co., Ltd. | 10.87 Billion KRW | -544.663% |
| Bioneer Corporation | 10.04 Billion KRW | -597.865% |
| Anterogen.Co.,Ltd. | -437.82 Million KRW | 16108.253% |
| MEDIPOST Co., Ltd. | -19.39 Billion KRW | 461.434% |
| CrystalGenomics, Inc. | -42.79 Billion KRW | 263.768% |
| Helixmith Co., Ltd | -53 Billion KRW | 232.231% |
| Medy-Tox Inc. | 32.69 Billion KRW | -114.349% |
| Peptron, Inc. | -12.65 Billion KRW | 654.033% |
| Amicogen, Inc. | 13.95 Billion KRW | -402.31% |
| Genexine, Inc. | -40.87 Billion KRW | 271.456% |
| HLB Therapeutics Co.,Ltd. | 8.22 Billion KRW | -751.66% |
| LegoChem Biosciences, Inc. | -71.38 Billion KRW | 198.184% |
| ALTEOGEN Inc. | 440.04 Million KRW | -15827.589% |
| PharmaResearch Co., Ltd. | 104.25 Billion KRW | 32.772% |
| SillaJen, Inc. | -17.35 Billion KRW | 503.908% |
| JETEMA, Co., Ltd. | 11 Billion KRW | -536.715% |
| OliX Pharmaceuticals,Inc | -11.13 Billion KRW | 729.436% |
| Genomictree Inc. | -6.33 Billion KRW | 1206.915% |
| MedPacto, Inc. | -32.6 Billion KRW | 314.937% |
| D&D Pharmatech | -9.05 Billion KRW | 873.778% |
| EASY BIO,Inc. | 24.32 Billion KRW | -188.153% |
| GI Innovation, Inc. | -51.33 Billion KRW | 236.543% |